Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal


Suchbegriffe: BONE RESORPTION - DRUG THERAPY , . Treffer: 3


Milovanovic, P; Zimmermann, EA; Riedel, C; vom Scheidt, A; Herzog, L; Krause, M; Djonic, D; Djuric, M; Püschel, K; Amling, M; Ritchie, RO; Busse, B Multi-level characterization of human femoral cortices and their underlying osteocyte network reveal trends in quality of young, aged, osteoporotic and antiresorptive-treated bone.
Biomaterials. 2015; 45(12): 46-55. Doi: 10.1016/j.biomaterials.2014.12.024
Web of Science PubMed FullText FullText_MUG



Fahrleitner-Pammer, A; Piswanger-Soelkner, JC; Pieber, TR; Obermayer-Pietsch, BM; Pilz, S; Dimai, HP; Prenner, G; Tscheliessnigg, KH; Hauge, E; Portugaller, RH; Dobnig, H Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial.
J Bone Miner Res. 2009; 24(7): 1335-1344. Doi: 10.1359/jbmr.090216 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar



Hermann, J; Mueller, T; Fahrleitner, A; Dimai, HP Early onset and effective inhibition of bone resorption in patients with rheumatoid arthritis treated with the tumour necrosis factor alpha antibody infliximab.
CLIN EXP RHEUMATOL 2003 21: 473-476.
Web of Science PubMed


© Med Uni Graz Impressum